Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Activities

VHIR & BIOCAT – ATMP Catalonia Series: 'ATMPs: From Preclinical Discovery to First-in-Human Trials'

The CORE of Innovative and Advanced Therapies at VHIR, together with the Catalan Advanced Therapies Network of BIOCAT and within the framework of the ATMP Catalonia Series, is organizing the initiative “ATMPs: From Preclinical Discovery to First-in-Human Trials”.This conference will focus

News

The Gen Rebelde Foundation donates €25,000 to boost research into gene therapy for GNB1 encephalopathy at Vall d’Hebron

The Gen Rebelde Foundation has made its first donation of the year to the gene therapy research project for GNB1 encephalopathy.

Activities

Defensa de Tesi 'New approaches in the management of preeclampsia with cerium oxide nanoparticles'

Doctoranda: Joana Ramis García, grup de Recerca Nanopartícules farmacocinètiques. Vall d'Hebron Institut de Recerca (VHIR)Directors: Dr. Víctor Franco Puntes i Dr. Joan Comenge FarréTutora: Dr. Julia Lorenzo Rivera 

News

Vall d’Hebron and the University Hospital of Santa Maria in Lleida identify several cases of a rare disease transmitted by a sperm donor

The study describes the first documented case worldwide of hereditary angioedema transmission through assisted reproduction.

Activities

IV Curs 'Fàrmacs i Malaltia Renal'

Dra. Maria Queralt Gorgas Torner, Cap de Servei, Servei de Farmàcia, Hospital Universitari Vall d’HebronDra. Laura Gómez Ganda, Farmacèutica Adjunta, Servei de Farmàcia, Hospital Universitari Vall d'Hebron

News

A family-led solidarity initiative raises €15,830 for research into paediatric autoimmune hepatitis at Vall d’Hebron

The donation will support a research line focused on understanding the progression of this inflammatory liver disease and improving treatment personalisation.

Activities

Vall d'Hebron Talks by VHIR 'Development of a non-invasive molecular diagnostic tool for Endometriosis'

Speaker: Raquel Delgado Gil. Predoctoral researcher Biomedical Research in Gynaecology. Vall d'Hebron Research Institute (VHIR).Abstract: Endometriosis is a benign gynecological condition characterized by the presence of endometrial-like tissue outside the uterine cavity, affecting around

Activities

XI Jornada de Nutrició Clínica Vall d’Hebron

Coordinadors:Dr. David Berlana. Àrea de Nutrició del Servei de Farmàcia. Hospital Universitari Vall d'Hebron. Barcelona.Dra. Rosa Burgos. Unitat de Suport Nutricional, Servei d'Endocrinologia i Nutrició. Hospital Universitari Vall d'Hebron. Barcelona.

News

Montserrat Aran, finalist in the National Awards of the General Council of Nursing for a humanization project in the ICU

The recognition highlights the Cuidador Acompañante project, a nursing-led initiative that promotes the active and safe participation of families in the Intensive Care Unit (ICU).

News

VHIR spin-off NEMA HEALTH closes €1 million funding round to tackle metastatic melanoma

The funds will enable the company to accelerate the preclinical phase and explore the application of its immunotherapy in other types of cancer.

News

Diesel particles increase the risk of severe cardiac arrhythmias, while antioxidant cerium oxide nanoparticles could protect the heart

A study led by the Vall d'Hebron Research Institute (VHIR) demonstrates the causal role of air pollution in ventricular arrhythmias and identifies a possible therapeutic strategy based on antioxidants.

Activities

Defensa de Tesi 'Tolerància de l'ecografia transvaginal en l'endometriosi profunda: anàlisi dels factors moduladors i impacte de la realitat virtual en l'experiència de les pacients'

Doctoranda: Anna Ruano López, grup de recerca Biomèdica en Ginecologia. Vall d'Hebron Institut de Recerca (VHIR).Directores: Dra. Elena Suárez Salvador i Dra. Jordina Munrós Feliu.Tutor: Dr. Antonio Gil Moreno. 

Activities

Monòlegs solidaris

https://vallhebron.org/iniciativa-hepatitis-autoinmune-infantil 

Activities

The Omics Revolution: NGS for a Data-Driven Future

This conference has been organized and features the participation of Dr. Josep Quer, Principal Investigator of the Liver Diseases Group at VHIR and Group Leader at CIBEREHD, and Dr. Rosa Prieto, Head of the High Technology Unit at VHIR..

News

Vall d’Hebron takes part in a study showing the long-term benefits of ruxolitinib in paediatric graft-versus-host disease

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

Activities

Vall d'Hebron Talks 'Estudi de les seqüeles a mitjà i llarg termini de la traqueostomia percutània a la fonació, deglució i respiració'

Ponent: Neus Pelay Panés. Infermera Adjunta a la Direcció - AC Diagnòstic per Imatge Laboratoris Clínics, Tractament Malalties Infeccioses, Endocrinologia, Metabolisme i Nutrició. Hospital Universitari Vall d’Hebron.Resum: La traqueostomia percutània (TQP) és un procediment freqüent a la U

Activities

Institutional Seminar Series: 'Circadian clock communication in health, ageing and disease'

Speaker: Thomas Mortimer. Postdoctoral Fellow Stem Cells and Cancer Laboratory. Institut de Recerca Biomèdica Barcelona (IRB).Abstract:  A breakdown of mechanisms maintaining cellular, tissue and systemic homeostasis is a conserved feature of ageing.

Activities

70 anys Vall d'Hebron: passat, present i futur

Aquesta trobada vol ser un espai de reflexió per posar en valor la trajectòria de l’Hospital Universitari Vall d’Hebron al llarg de la seva història, des d'abans de la seva creació ara fa més de 70 anys, fins al present i els projectes de futur. La sessió serà retra

Activities

Vall d'Hebron Talks by VHIR 'Targeting Immunothrombosis to Restore Brain Flow and Function'

Speaker: Dr. María Ángeles Moro. Leader of the Neurovascular Pathophysiology Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC). She is also Coordinator of the CNIC “Cardiovascular Risk Factors and Brain Health” programme, co-leads the Neurovascular Research Unit (